Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Zhang, Chi ^a,b,c   Lu, Xuemian ^a   Tan, Yi ^b,c   Li, Bing ^c,d   Miao, Xiao ^c,d   Jin, Litai ^b   Shi, Xue ^e   Zhang, Xiang ^e   Miao, Lining ^d   Li, Xiaokun ^b   Cai, Lu ^a,b,c  

^a THE THIRD AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c University of Louisville School of Medicine   (United States)

^d THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^e UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GLYCOGEN SYNTHASE KINASE 3BETA; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PROTEIN KINASE B; TRANSCRIPTION FACTOR NRF2; ZINC;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIPID STORAGE; LIVER INJURY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STREPTOZOCIN DIABETES; SUPPLEMENTATION; UPREGULATION; ZINC DEFICIENCY;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; MICE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; ZINC;

MUS;

EID: 84871255763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049257     Document Type: Article

References (47)

1. Manna P, Das J, Ghosh J, Sil PC, (2010) Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Free Radic Biol Med 48: 1465-1484.
2. de Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, et al. (1999) Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22: 756-761.
3. Harrison SA, (2006) Liver disease in patients with diabetes mellitus. J Clin Gastroenterol 40: 68-76.
4. Baig NA, Herrine SK, Rubin R, (2001) Liver disease and diabetes mellitus. Clin Lab Med 21: 193-207.
5. Adiels M, Taskinen MR, Boren J, (2008) Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep 8: 60-64.
6. Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, et al. (2008) Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. Hepatogastroenterology 55: 609-614.
7. DeFronzo RA, Hendler R, Simonson D, (1982) Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 31: 795-801.
8. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, et al. (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342: 883-887.
9. Bulum T, Kolaric B, Duvnjak L, Duvnjak M, (2011) Nonalcoholic Fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci 56: 3655-3663.
10. Smith BW, Adams LA, (2011) Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7: 456-465.
11. Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH, (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37: 1182-1190.
12. Jansen J, Karges W, Rink L, (2009) Zinc and diabetes-clinical links and molecular mechanisms. J Nutr Biochem 20: 399-417.
13. Mohommad MK, Zhou Z, Cave M, Barve A, McClain CJ, (2012) Zinc and liver disease. Nutr Clin Pract 27: 8-20.
14. Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, et al. (1988) Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 8: 1605-1609.
15. Goode HF, Kelleher J, Walker BE, (1990) Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 31: 694-697.
16. Gil Extremera B, Maldonado Martin A, Ruiz Martinez M, Cantero Hinojosa J, Diez Ruiz A, et al. (1990) Zinc and liver cirrhosis. Acta Gastroenterol Belg 53: 292-298.
17. Szuster-Ciesielska A, Daniluk J, Bojarska-Junak A, (2005) Apoptosis of blood mononuclear cells in alcoholic liver cirrhosis. The influence of in vitro ethanol treatment and zinc supplementation. Toxicology 212: 124-134.
18. Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, et al. (2005) Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 166: 1681-1690.
19. Adler M, Dinterman RE, Wannemacher RW, (1997) Protection by the heavy metal chelator N,N,N′,N′-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN) against the lethal action of botulinum neurotoxin A and B. Toxicon 35: 1089-1100.
20. Yamaguchi S, Miura C, Kikuchi K, Celino FT, Agusa T, et al. (2009) Zinc is an essential trace element for spermatogenesis. Proc Natl Acad Sci U S A 106: 10859-10864.
21. Cai L, Chen S, Evans T, Cherian MG, Chakrabarti S, (2002) Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats. Int J Exp Diabetes Res 3: 193-198.
22. Zhao Y, Tan Y, Dai J, Li B, Guo L, et al. (2011) Exacerbation of diabetes-induced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38 MAPK activation, and p53 activation in mice. Toxicol Lett 200: 100-106.
23. Lee JM, Johnson JA, (2004) An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 37: 139-143.
24. He X, Kan H, Cai L, Ma Q, (2009) Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. J Mol Cell Cardiol 46: 47-58.
25. Shumaker DK, Vann LR, Goldberg MW, Allen TD, Wilson KL, (1998) TPEN, a Zn2+/Fe2+ chelator with low affinity for Ca2+, inhibits lamin assembly, destabilizes nuclear architecture and may independently protect nuclei from apoptosis in vitro. Cell Calcium 23: 151-164.
26. Nakatani T, Tawaramoto M, Opare Kennedy D, Kojima A, Matsui-Yuasa I, (2000) Apoptosis induced by chelation of intracellular zinc is associated with depletion of cellular reduced glutathione level in rat hepatocytes. Chem Biol Interact 125: 151-163.
27. Chai F, Truong-Tran AQ, Ho LH, Zalewski PD, (1999) Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review. Immunol Cell Biol 77: 272-278.
28. Lopez JJ, Redondo PC, Salido GM, Pariente JA, Rosado JA, (2009) N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and-8 in human platelets. A role for endoplasmic reticulum stress. J Thromb Haemost 7: 992-999.
29. Ra H, Kim HL, Lee HW, Kim YH, (2009) Essential role of p53 in TPEN-induced neuronal apoptosis. FEBS Lett 583: 1516-1520.
30. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, et al. (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106: 2067-2072.
31. Alexandraki KI, Piperi C, Ziakas PD, Apostolopoulos NV, Makrilakis K, et al. (2008) Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol 28: 314-321.
32. Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, et al. (2008) Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. J Am Coll Nutr 27: 577-587.
33. Vignolini F, Nobili F, Mengheri E, (1998) Involvement of interleukin-1beta in zinc deficiency-induced intestinal damage and beneficial effect of cyclosporine A. Life Sci 62: 131-141.
34. DiSilvestro RA, Carlson GP, (1994) Effects of mild zinc deficiency, plus or minus acute phase response, on CCl4 hepatotoxicity. Free Radic Biol Med 16: 57-61.
35. Xu J, Wang G, Wang Y, Liu Q, Xu W, et al. (2009) Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection. J Cell Mol Med 13: 1499-1512.
36. Ji C, Kaplowitz N, (2006) ER stress: can the liver cope? J Hepatol 45: 321-333.
37. Jain AK, Jaiswal AK, (2007) GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282: 16502-16510.
38. Niture SK, Kaspar JW, Shen J, Jaiswal AK, (2010) Nrf2 signaling and cell survival. Toxicol Appl Pharmacol 244: 37-42.
39. Haase H, Maret W, (2005) Fluctuations of cellular, available zinc modulate insulin signaling via inhibition of protein tyrosine phosphatases. J Trace Elem Med Biol 19: 37-42.
40. Haase H, Maret W, (2005) Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18: 333-338.
41. Wu W, Wang X, Zhang W, Reed W, Samet JM, et al. (2003) Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. J Biol Chem 278: 28258-28263.
42. Mocanu MM, Yellon DM, (2009) Letter to the editor: "Zinc and cardioprotection: the missing link". Am J Physiol Heart Circ Physiol 296: H233-234.
43. Carracedo A, Pandolfi PP, (2008) The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene 27: 5527-5541.
44. Brandao-Neto J, Silva CA, Figueiredo NB, Shuhama T, Holanda MB, et al. (2000) Zinc kinetics in insulin-dependent diabetes mellitus patients. Biometals 13: 141-145.
45. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ, (1983) Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 75: 273-277.
46. Fischer Walker CL, Ezzati M, Black RE, (2009) Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur J Clin Nutr 63: 591-597.
47. Hambidge KM, Krebs NF, (2007) Zinc deficiency: a special challenge. J Nutr 137: 1101-1105.